PEG-GCSF (pegfilgrastim biosimilar)
/ PharmaEssentia
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 30, 2025
A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=30 | Completed | Sponsor: PharmaEssentia | Trial completion date: Jun 2025 ➔ Feb 2025 | Enrolling by invitation ➔ Completed
Trial completion • Trial completion date
November 21, 2024
P2203 phase I: A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=30 | Enrolling by invitation | Sponsor: PharmaEssentia
New P1 trial
1 to 2
Of
2
Go to page
1